The Welllife Journal
Animal studies and limited human data show that semaglutide and tirzepatide transfer into breast milk at measurable concentrations
From July 1, 2026, Medicare will cover Wegovy and Zepbound for weight loss through a temporary federal program called the Medicare GLP-1 bridge: with a new model coming into place in 2027
Utilization Management With this latest action, PBMs will develop coverage criteria for Medicare payers in addition to securing rebates and financial terms with manufacturers
We have nothing at that time No website, we had a website, but it was like a nothing nothing crazy So 2021 [00:25:00] was the first launch of the product now we are here today, but, so anyways, so thanks for asking me this question, but I just wanna make sure the story Michelle Oravitz: Yeah, no, I love the story because I think also I have very, very smart listeners, I'll be honest, like with a fertility journey, they are so educated
Click on the Book Appointment button